Effect of vitamin C administration on gastric colonization by Helicobacter pylori;Efeito da administração de vitamina C sobre a colonização do estêmago por Helicobacter pylori

Arquivos de Gastroenterologia

Volumn 42, Issue 3, 2005, Pages 167-172

  Kamiji, Mayra Mayumi ^a,b   De Oliveira, Ricardo Brandt ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIOXIDANT; ASCORBIC ACID; CARBON 14; OMEPRAZOLE; PLACEBO;

ABDOMINAL DISTENSION; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; CHRONIC GASTRITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ERADICATION THERAPY; FLATULENCE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFECTION CONTROL; NAUSEA; PEPTIC ULCER; RANDOMIZED CONTROLLED TRIAL; STOMACH PAIN; TREATMENT FAILURE; UREA BREATH TEST;

EID: 27444436743     PISSN: 00042803     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-28032005000300008     Document Type: Article

References (31)

1. Auer BL, Auer D, Rodgers AL. Relative hyperoxaluria, crystalluria and haematuria after megadose ingestion of vitamin C. Eur J Clin Invest 1998;28:695-700.
2. Banerjee S, Hawksby C, Miller S, Dahill S, Beattie AD, Mccoll KE. Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid. Gut 1994;35:317-22.
3. Carson CF, Riley TV. Non-antibiotic therapies for infectious diseases. Commun Dis Intell 2003;27(Suppl):143s-6s.
4. Chalmers AH, Cowley DM, McWhinney BC. Stability of ascorbate in urine: relevance to analyses for ascorbate and oxalate. Clin Chem 1985;31:1703-5.
5. Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, Realpe JL, Malcom GT, Li D, Johnson WD, Mera R. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst 2000;92:1881-8.
6. Cover TL, Blaser MJ. Helicobacter pylori infection, a paradigm for chronic mucosal inflammation: pathogenesis and implications for erradication and prevention. Adv Intern Med 1996;41:85-117.
7. Dabrowska-Ufniarz E, Dzieniszewski J, Jarosz M, Wartanowicz M. Vitamin C concentration in gastric juice in patients with precancerous lesions of the stomach and gastric cancer. Med Sci Monit 2002;8:96-103.
8. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids: a report of the Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academy Press; 2000. p.95-161.
9. Feiz HR, Mobarhan S. Does vitamin C intake slow the progression of gastric cancer in Helicobacter pylori-infected populations? Nutr Rev 2002;60:34-7.
10. Go MF. Natural history of Helicobacter pylori infection. Aliment Pharmacol Ther 2002;16(Suppl 1):3-15.
11. Goddard AF, Logan RP. Diagnostic methods for Helicobacter pylori detection and eradication. Br J Clin Pharmacol 2003;56:273-83.
12. 14C-urea breath test for the diagnosis of Helicobacter pylori. São Paulo Med J 2002;120:68-71.
13. Huang AH, Sheu BS, Yang HB, Huang CC, Wu JJ, Lin XZ. Impact of Helicobacter pylori antimicrobial resistance on the outcome of 1-week lansoprazole-based triple therapy. J Formos Med Assoc 2000;99:704-9.
14. Jarosz M, Dzieniszewski J, Dabrowska-Ufniarz E, Wartanowicz M, Zielamski S, Reed PI. Effects of high dose vitamin C treatment on Helicobacter pylori infection and total vitamin C concentration in gastric juice. Eur J Cancer Prev 1998;7:449-54.
15. Johnston CS. Biomarkers for establishing a tolerable upper intake for vitamin C. Nutr Rev 1999;57:71-7.
16. Ko̧kar C, Oztürk M, Bavbek N. Helicobacter pylori eradication with beta carotene, ascorbic acid and allicin. Acta Medica (Hradec Kralove) 2001;44:97-100.
17. Lee KW, Lee HJ, Surh YJ, Lee CY. Vitamin C and cancer chemoprevention: reappraisal. Am J Clin Nutr 2003;78:1074-8.
18. Levine M, Conry-Cantinela C, Wang T, Welch RW, Washko PW, Dhariwal KR, Park JB, Lazarev A, Graumlich JF, King J, Cantilena LR. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci USA 1996;93:3704-9.
19. Liebman M, Chai W, Harvey H, Boenisch L. Effect of supplemental ascorbate and orange juice on urinary oxalate. Nutr Res 1997;17:415-25.
20. Marshall BJ, Warren JR. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;l:1273-5.
21. Marshall BJ. The 14 C urea breath. In: Helicobacter pylori: techniques for clinical diagnosis and basic research. London: WB Saunders; 1996. p.83-93.
22. Mowat C, Carswell A, Wirz A, McColl KE. Omeprazole and dietary nitrate independently affect levels of vitamin C and nitrite in gastric juice. Gastroenterology 1999;116:813-22.
23. Mowat C, Williams C, Gillen D, Hossack M, Gilmour D, Carswell A, Wirz A, Preston T, McCoIl KE. Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation. Gastroenterology 2000;119:339-47.
24. Nakamoto Y, Motohashi S, Kasahara H, Numazawa K. Irreversible tubulointerstitial nephropathy associated with prolonged, massive intake of vitamin C. Nephrol Dial Transplant 1998;13:754-6.
25. Qasim A, O'Morain CA. Treatment of Helicobacter pylori infection and factors influencing eradication. Aliment Pharmacol Ther 2002;16 (Suppl1):24-30.
26. Rokkas T, Papatheodorou G, Karameris A, Mavrogeorgis A, Kalogeropoulos N, Giannikos N. Helicobacter pylori infection and gastric juice vitamin C levels. Impact of eradication. Dig Dis Sci 1995;40:615-21.
27. Ruiz B, Rood JC, Fontham ET, Malcom, GT, Hunter FM, Sobhan M, WD, Correa P. Vitamin C concentration in gastric juice before and after anti-Helicobacter pylori treatment. Am J Gastroenterol 1994;89:533-9.
28. Sabate E, Burkhart PV. Adherence to long-term therapies: evidence for action. J Nurs Scholarsh 2003;35:207.
29. Simon R. Confidence intervals for reporting results of clinical trials. Ann Intern Med 1986;105:429-35.
30. Tsao CS, Salimi SL. Effect of large intake of ascorbic acid on urinary and plasma oxalic acid levels. Int J Vitam Nutr Res 1984;54:245-9.
31. van Leerdam ME, Tytgat GN. Review article: Helicobacter pylori infection in peptic ulcer haemorrhage. Aliment Pharmacol Ther 2002;16 (Suppl1):66-78.